Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05561842 · ClinicalTrials.gov registry record
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)
A clinical trial of Breast Cancer and Breast Cancer Female, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 900
- Enrollment target
- 8
- Study locations
NCT05561842 is a study of Breast Cancer and Breast Cancer Female that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 900 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (68% lower). The trial reports 8 study locations across 6 states.
The verdict
NCT05561842, a study of Breast Cancer and Breast Cancer Female, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 900 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this study is to train Nigerian radiologists to perform ultrasound-guided breast biopsies. Researchers will use mHealth devices to create a sustainable and practical way of training radiologists in Nigeria to perform and clinically implement US-guided breast biopsies into their practice.
Conditions Studied
Interventions
- PROCEDURE mHealth US-breast biopsy
Study Locations (8)
Other
- University Of Nigeria Teaching Hospital (UNTH) Ituku-Ozalla Enugu - Enugu
- Obafemi Awolowo University Teaching Hospitals Complex (Data Collection Only) - Ile-Ife
- University of Ilorin Teaching Hospitals - Ilorin
New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
Lagos
- Lagos University Teaching Hospital - Idi Araba
Ogun State
- Olabisis Onabanjo University Teaching Hospital (Data Collection Only) - Sagamu
Ondo State
- Federal Medical Centre Owo (Data Collection Only) - Owo
Oyo State
- University College Hospital (Data Collection Only) - Ibadan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2022-09-21 |
| Est. Completion | 2027-09-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05561842
The ClinicalTrials.gov registry entry for NCT05561842 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (68% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which mHealth US-breast biopsy is the first listed.
NCT05561842 reports 8 study locations spanning 6 distinct geographic areas - top geographies include Other, New York, Lagos.
Frequently Asked Questions
What is clinical trial NCT05561842 about?
NCT05561842 is a clinical study titled "Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)". The purpose of this study is to train Nigerian radiologists to perform ultrasound-guided breast biopsies. Researchers will use mHealth devices to create a sustainable and practical way of training radiologists in Nigeria to perform and clinically implement US-guided breast biopsies into their practi...
What is the current status of trial NCT05561842?
This trial is currently recruiting. The enrollment target is 900 participants. The study started on 2022-09-21. Estimated completion is 2027-09-21.
What conditions does trial NCT05561842 study?
This clinical trial studies the following conditions: Breast Cancer, Breast Cancer Female.
What interventions are being tested in trial NCT05561842?
The interventions under investigation include: mHealth US-breast biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT05561842?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05561842 being conducted?
This trial has 8 study locations across New York, Lagos, Ogun State, Ondo State, Oyo State. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.